ID   B240
AC   CVCL_L056
DR   Cell_Model_Passport; SIDM01683
DR   Wikidata; Q54752577
RX   PubMed=1664237;
RX   PubMed=9680106;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L055 ! B239
OI   CVCL_1835 ! NALM-19
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
RX   PubMed=1664237;
RA   Matsuo Y., Ariyasu T., Adachi T., Tsubota T., Imanishi J.,
RA   Minowada J.;
RT   "Establishment and characterization of a bi-phenotypic leukemic cell
RT   line, NALM-19, from a patient with acute leukemia.";
RL   Hum. Cell 4:257-260(1991).
//
RX   PubMed=9680106; DOI=10.1016/S0145-2126(98)00050-2;
RA   Matsuo Y., Drexler H.G.;
RT   "Establishment and characterization of human B cell precursor-leukemia
RT   cell lines.";
RL   Leuk. Res. 22:567-579(1998).
//